257 related articles for article (PubMed ID: 32649887)
1. Immunogenomic Landscape of Hematological Malignancies.
Dufva O; Pölönen P; Brück O; Keränen MAI; Klievink J; Mehtonen J; Huuhtanen J; Kumar A; Malani D; Siitonen S; Kankainen M; Ghimire B; Lahtela J; Mattila P; Vähä-Koskela M; Wennerberg K; Granberg K; Leivonen SK; Meriranta L; Heckman C; Leppä S; Nykter M; Lohi O; Heinäniemi M; Mustjoki S
Cancer Cell; 2020 Sep; 38(3):380-399.e13. PubMed ID: 32649887
[TBL] [Abstract][Full Text] [Related]
2. Gene profiling of lymphoma, myeloma, and AML.
Rogge L; Bianchi E
MedGenMed; 2003 Jul; 5(3):12. PubMed ID: 14600649
[No Abstract] [Full Text] [Related]
3. Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells.
Liu A; Takahashi M; Toba K; Zheng Z; Hashimoto S; Nikkuni K; Furukawa T; Koike T; Aizawa Y
Hematol Oncol; 1999 Dec; 17(4):149-60. PubMed ID: 10725870
[TBL] [Abstract][Full Text] [Related]
4. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
Fröhlich A; Loick S; Bawden EG; Fietz S; Dietrich J; Diekmann E; Saavedra G; Fröhlich H; Niebel D; Sirokay J; Zarbl R; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
EBioMedicine; 2020 Feb; 52():102647. PubMed ID: 32028068
[TBL] [Abstract][Full Text] [Related]
6. PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas.
Pascual M; Mena-Varas M; Robles EF; Garcia-Barchino MJ; Panizo C; Hervas-Stubbs S; Alignani D; Sagardoy A; Martinez-Ferrandis JI; Bunting KL; Meier S; Sagaert X; Bagnara D; Guruceaga E; Blanco O; Celay J; Martínez-Baztan A; Casares N; Lasarte JJ; MacCarthy T; Melnick A; Martinez-Climent JA; Roa S
Blood; 2019 May; 133(22):2401-2412. PubMed ID: 30975638
[TBL] [Abstract][Full Text] [Related]
7. A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations.
Tamborero D; Rubio-Perez C; Muiños F; Sabarinathan R; Piulats JM; Muntasell A; Dienstmann R; Lopez-Bigas N; Gonzalez-Perez A
Clin Cancer Res; 2018 Aug; 24(15):3717-3728. PubMed ID: 29666300
[No Abstract] [Full Text] [Related]
8. p53 dysregulation in B-cell malignancies: More than a single gene in the pathway to hell.
Tessoulin B; Eveillard M; Lok A; Chiron D; Moreau P; Amiot M; Moreau-Aubry A; Le Gouill S; Pellat-Deceunynck C
Blood Rev; 2017 Jul; 31(4):251-259. PubMed ID: 28284458
[TBL] [Abstract][Full Text] [Related]
9. Genomic and Immunological Tumor Profiling Identifies Targetable Pathways and Extensive CD8+/PDL1+ Immune Infiltration in Inflammatory Breast Cancer Tumors.
Hamm CA; Moran D; Rao K; Trusk PB; Pry K; Sausen M; Jones S; Velculescu VE; Cristofanilli M; Bacus S
Mol Cancer Ther; 2016 Jul; 15(7):1746-56. PubMed ID: 27196778
[TBL] [Abstract][Full Text] [Related]
10.
Godfrey J; Tumuluru S; Bao R; Leukam M; Venkataraman G; Phillip J; Fitzpatrick C; McElherne J; MacNabb BW; Orlowski R; Smith SM; Kline J
Blood; 2019 May; 133(21):2279-2290. PubMed ID: 30910787
[TBL] [Abstract][Full Text] [Related]
11. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors.
Dangaj D; Bruand M; Grimm AJ; Ronet C; Barras D; Duttagupta PA; Lanitis E; Duraiswamy J; Tanyi JL; Benencia F; Conejo-Garcia J; Ramay HR; Montone KT; Powell DJ; Gimotty PA; Facciabene A; Jackson DG; Weber JS; Rodig SJ; Hodi SF; Kandalaft LE; Irving M; Zhang L; Foukas P; Rusakiewicz S; Delorenzi M; Coukos G
Cancer Cell; 2019 Jun; 35(6):885-900.e10. PubMed ID: 31185212
[TBL] [Abstract][Full Text] [Related]
12. Prognosis, Biology, and Targeting of
Flynt E; Bisht K; Sridharan V; Ortiz M; Towfic F; Thakurta A
Cells; 2020 Jan; 9(2):. PubMed ID: 31991614
[TBL] [Abstract][Full Text] [Related]
13. Hematopoiesis in patients with mature B-cell malignancies is deregulated even in patients with undetectable bone marrow involvement.
Maswabi BC; Molinsky J; Savvulidi F; Zikmund T; Prukova D; Tuskova D; Klanova M; Vockova P; Lateckova L; Sefc L; Zivny J; Trneny M; Klener P
Haematologica; 2017 Apr; 102(4):e152-e155. PubMed ID: 28057744
[No Abstract] [Full Text] [Related]
14. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.
Li B; Severson E; Pignon JC; Zhao H; Li T; Novak J; Jiang P; Shen H; Aster JC; Rodig S; Signoretti S; Liu JS; Liu XS
Genome Biol; 2016 Aug; 17(1):174. PubMed ID: 27549193
[TBL] [Abstract][Full Text] [Related]
15. Cancer immune therapy for myeloid malignancies: present and future.
Holmström MO; Hasselbalch HC
Semin Immunopathol; 2019 Jan; 41(1):97-109. PubMed ID: 29987478
[TBL] [Abstract][Full Text] [Related]
16. Immune gene expression profiling reveals heterogeneity in luminal breast tumors.
Zhu B; Tse LA; Wang D; Koka H; Zhang T; Abubakar M; Lee P; Wang F; Wu C; Tsang KH; Chan WC; Law SH; Li M; Li W; Wu S; Liu Z; Huang B; Zhang H; Tang E; Kan Z; Lee S; Park YH; Nam SJ; Wang M; Sun X; Jones K; Zhu B; Hutchinson A; Hicks B; Prokunina-Olsson L; Shi J; Garcia-Closas M; Chanock S; Yang XR
Breast Cancer Res; 2019 Dec; 21(1):147. PubMed ID: 31856876
[TBL] [Abstract][Full Text] [Related]
17. [Significance of the HL-A-antigensystem in tumor research].
Kuwert E; Bertrams J
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 78(2):204-18. PubMed ID: 4264844
[No Abstract] [Full Text] [Related]
18. [The induction of the antitumor activity of T-lymphocytes by antigen-presenting cells obtained from the blast cells of patients with acute leukemias].
Savchenko VG; Sadovnikova EIu; Parovichnikova EN; Mendeleeva LP; Demidova IA; Sokolov AN; Isaev VG
Ter Arkh; 2000; 72(7):14-21. PubMed ID: 10983315
[TBL] [Abstract][Full Text] [Related]
19. Immunologic studies in lymphoma and leukemia, and exploration of antitumor immunotherapy.
Sokal JE
J Surg Oncol; 1973 Jun; 5(6):557-66. PubMed ID: 4589652
[No Abstract] [Full Text] [Related]
20. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
